Your report reviewed by the Quenet Torrent team in 48 h +34 660 65 82 76
30+ years of experience
3,000+ CRS+HIPEC procedures
International multidisciplinary committee
Research

What does the PRODIGE 7 study teach us?

Phase III study on cytoreductive surgery with HIPEC in colorectal peritoneal carcinomatosis

03/01/2018 · Dr. François Quenet · The Lancet Oncology

What does the PRODIGE 7 study teach us?
Dr. François Quenet

Article written by

Dr. François Quenet

Quenet Torrent Institute

View full profile

The PRODIGE 7 study, led by Prof. Dr. François Quenet, provides data on the role of HIPEC with oxaliplatin in peritoneal carcinomatosis of colorectal origin.

References

Published in: The Lancet Oncology (2021)

DOI: 10.1016/S1470-2045(20)30599-4

View original article
Easy Contact

Need to speak with a specialist?

Complete the form and schedule your appointment to speak directly with the surgeon.

Request consultation

Message us on WhatsApp